fbpx

Tiny valve is a breath of fresh air

  • Posted by Chris Kellett
  • On March 29, 2016
Late-stage emphysema is a type of chronic obstructive pulmonary disease (COPD). While there is no cure, treatment can help …    
Read More

Pulmonx Names New Chief Executive Officer

  • Posted by Jenna Widdison
  • On December 18, 2015
December 18, 2015, Redwood City, California - Pulmonx Corporation, a leader in interventional pulmonology, today announced that Glen French has joined the company as President, Chief Executive Officer and member of the Board of Directors. Mr. French posesses deep experience leading and transforming...
Read More

New England Journal of Medicine Publishes Groundbreaking Study Demonstrating Benefits of Medical Device for Emphysema

  • Posted by Jenna Widdison
  • On December 9, 2015
New England Journal of Medicine Publishes Groundbreaking Study Demonstrating Benefits of Medical Device for Emphysema First Prospective, Randomized Controlled Study Using the Chartis System to Select Patients Confirms Clinical Superiority of Zephyr® EBV Therapy over Medical Management in Treating Emphysema Redwood City, Calif. – December 9, 2015 – Pulmonx Corporation, a leader in interventional pulmonology,...
Read More

Pulmonx Starts UK Clinical Trial at Royal Brompton Hospital with Minimally Invasive Lung Valve Treatment Offering Hope to Emphysema Patients

  • Posted by Jenna Widdison
  • On October 18, 2015
London, UK, October 28, 2015 – A clinical trial recently commenced at Royal Brompton Hospital to evaluate a minimally-invasive valve based treatment that may help patients suffering from severe emphysema breathe easier without surgery. Emphysema is a form of chronic obstructive pulmonary disease...
Read More

Pulmonx’s Zephyr® Endobronchial Valve Demonstrates Statistically and Clinically Significant Results in a Prospective, Randomized Controlled Trial

  • Posted by Jenna Widdison
  • On September 9, 2015
September 09, 2014, Redwood City & Munich - The results of BeLieVeR-HIFi trial, the first double-blinded, randomized, controlled clinical trial to assess the impact of the Zephyr® Endobronchial Valve (EBV) for the treatment of emphysema, were presented today at the 2014 European Respiratory Society...
Read More

Lancet Publication of Sham-Controlled Clinical Trial Shows Pulmonx’s Zephyr® Endobronchial Valves Deliver Significant Benefit to Emphysema Patients

  • Posted by Jenna Widdison
  • On July 1, 2015
REDWOOD CITY, Calif. – July 1, 2015 –Pulmonx®, a leader in interventional pulmonology, today announced publication in The Lancet of results from the BeLieVeR-HIFi clinical trial, the first successful sham-controlled trial of any minimally invasive emphysema device. BeLieVeR-HIFi is a prospective,...
Read More